Overview

Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare patient tumor tissue before and after treatment with chemotherapy plus celecoxib. Investigators will look at gene expression, to see what effect celecoxib may have on tumor cells.
Phase:
Phase 1
Details
Lead Sponsor:
Baylor College of Medicine
Treatments:
Celecoxib
Cisplatin
Gemcitabine